Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug- resistant cells

Cancer Research

Volumn 56, Issue 16, 1996, Pages 3626-3629

  Venne, Annie ^a   Li, Shengmin ^a   Mandeville, Rosemonde ^a   Kabanov, Alexander ^b   Alakhov, Valery ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPOLYMER; DOXORUBICIN; GLYCOPROTEIN P; POLOXAMER;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG SENSITIVITY; DRUG TRANSPORT; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL TRANSPORT; CHO CELLS; CRICETINAE; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; P-GLYCOPROTEIN; POLOXALENE; POLYMERS;

EID: 0029765581     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Chin, K. V., Pastan, I., and Gottesman, M. Function and regulation of the human multidrug resistance gene. Adv. Cancer Res., 60: 157-180, 1993.
2. Gottesman, M. M. How cancer cells evade chemotherapy: Sixteenth Richard and Hinda Rosental Foundation Award Lecture Cancer Res., 53: 747-754, 1993.
3. Alakhov, V Y., Moskaleva, E. Y., Batrakova, E. V , and Kabanov, A. V. Hypersensitization of multidrug resistant human ovarian carcinoma cell by pluronic P85 block copolymer. Bioconjugate Chem., 7: 209-216, 1996
4. Scudiero, D. A , Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S , Nofziger, T. H , Currens, M. J , Seniff, D , and Boyd, M. R Evaluation of a soluble tetrazolium/ formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res., 48: 4827-4833, 1988.
5. Luk, C. K., and Tannock, F. Flow cytometric analysis of doxorubicin accumulation in cells from human and rodent cell lines J. Natl. Cancer Inst , 81: 55-59, 1989
6. Ling, V., Kartner, N., Sudo, T., Siminovitch, L., and Riordan, J R. Multidrug resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep., 67: 869-874, 1983.
7. Fairchild, C. R., Ivy, S. P , Kao-Shan, C. S., Whang-Peng, J., Rosen, N., Israel, M. A., Melera, P. W., Cowan, K. H., and Goldsmith, M. E. Isolation of amplified and overexpressed DNA sequences from Adriamycin resistant human breast cancer cells. Cancer Res., 47: 5956-5964, 1987.
8. Fry, D. W. Biochemical pharmacology of anthracenediones and anthrapyrazoles Pharmacol. & Ther., 52: 109-125, 1991
9. Bernal, S. D., Lampidis, T J., Sumerhayes, I C., and Chen, L. B Rhodamine 123 selectively reduces clonal growth of carcinoma cells in vitro. Science (Washington DC), 10: 1117-1118, 1982.
10. Kabanov, A. V., Nazarova, I. R., Astafieva, I. V , Batrakova, E V., Alakhov, V. Y , Yaroslavov, A. A., and Kabanov, V. A. Micelle formation and solubilisation of fluorescent probes in poly(oxyethylene-b-oxyethylene-b-oxyethylene) solutions. Macromolecules, 28: 2303-2314, 1995.
11. Naito, M., and Tsuruo, T. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug resistance K562 cells without calcium ion involvement. Cancer Res., 49: 1452-1455, 1989.
12. Arsenaut, A L , Ling, V , and Kartner, N. Altered plasma membrane ultrastructure in multidrug resistant cells. Bichim. Biophys. Acta, 938: 315-321, 1988.
13. Krishan A Heterogeneity of anthracycline retention and response to efflux blockers in human tumors Cytometry, 21: 72-75, 1995.
14. Slepnev, V. I., Klushnenkova, L. E., Gubin, A N , Batrakova, E. V , Alakhov, V. Y., and Kabanov, A V. Micelles of poly(oxyethylene)-poly(oxypropylene) block copolymer as a tool for low molecular weight compound delivery into a cell. Biochem. Int., 24: 587-592, 1992.
15. Sognier, M A., Zhang, Y., Eberle, R. L., Sweet, K. M , Altenberg, G. A., and Belli, J A Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100) Biochem. Pharmacol., 48: 391-401, 1994
16. Schuurhuis, G. J. Broxterman, H. J., deLange J. H. M., Pinedo, H. M., van Heijningen, T. H. M , Kuiper, C. M., Scheffer, G. L., Scheper, R. J., van Kalken, C. K., Baak, J. P. A , and Lankelma, J. Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein Br. J Cancer, 64 857-861, 1991.
17. Schindler, M., Sharon, G., Hoff, E , and Simon, S. M. Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in Adriamycin-resistant cells (MCF-7/adr) Biochemistry. 35: 2811-2817, 1996.
18. Schuurhuis, G. J , Broxterman, H., and Cervantes, A Quantitative determination of factors contributing to doxorubicin resistance in multidrug resistant cells. J. Natl Cancer Inst., 81: 1887-1894, 1989.
19. Scheffer, G. L., Wijngaard, P. L. J., Flens, M. J., Izquierdo, M. A., Slovak, M. L., Pinedo, H. M., Meijer, C. J-L., Clevers, H. C., and Scheper, R. J. The drug resistance-related protein LRP is the human major vault protein. Nat. Med., 1: 578-582, 1995.
20. r 110.000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res., 53: 1475-1479, 1993.
21. Izquierdo, M. A., van der Zee, A. G. J , Vermorken, J B , van der Valk, P , Belien, J. A M., Giaccone, G., Scheffer, G L , Flens, M. J., Pinedo, H M., Kenemans, P., Meijer, C. J. L. M , de Vries, E G. E., and Scheper, R. J. Drug resistance-associated marker LRP for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J. Natl Cancer Inst., 87: 1231-1237, 1995.